1. Salvia miltiorrhiza Bunge extract and Przewalskin ameliorate Bleomycin-induced pulmonary fibrosis by inhibition of apoptosis, oxidative stress and collagen deposition via the TGF-β1 pathway
   Mengnan Zeng et al, 2024, Phytomedicine CrossRef
2. Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhibition of TLR4/MyD88/NF-κB pathway
   Yanhui Zhu et al, 2023, Journal of Ethnopharmacology CrossRef
3. Network-based pharmacology and UHPLC-Q-Exactive-Orbitrap-MS reveal Jinhua Qinggan granule's mechanism in reducing cellular inflammation in COVID-19
   Liping Qian et al, 2024, Frontiers in Immunology CrossRef
4. Recent advances in Chinese patent medicines entering the international market
   Bo Zhang et al, 2022, Drug Discoveries & Therapeutics CrossRef
5. COVID-19 Therapeutic Potential of Natural Products
   Zhaoxuan Low et al, 2023, International Journal of Molecular Sciences CrossRef
6. “Three medicines and three formulas” in COVID-19: from bench to bedside
   Guangxu Xiao et al, 2023, Acupuncture and Herbal Medicine CrossRef
7. Initial observations of Jinhua Qinggan Granules, a Chinese medicine, in the mitigation of hospitalization and mortality in high-risk elderly with COVID-19 infection: A retrospective study in an old age home in Hong Kong
   Timothy P. H. Lin et al, 2022, Frontiers in Medicine CrossRef
8. Chinese Medicine Meets Conventional Medicine in Targeting COVID-19 Pathophysiology, Complications and Comorbidities
   Shan-shan Wang et al, 2022, Chinese Journal of Integrative Medicine CrossRef